<DOC>
	<DOCNO>NCT01093807</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety various dosage combination lercanidipine ( 10 20 mg ) enalapril ( 10 20 mg ) comparison respective component placebo .</brief_summary>
	<brief_title>Efficacy Safety Lercanidipine Enalapril Patients With Essential Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Enalapril</mesh_term>
	<mesh_term>Enalaprilat</mesh_term>
	<mesh_term>Lercanidipine</mesh_term>
	<criteria>Office Blood Pressure ( BP ) : Sitting diastolic blood pressure ( SDBP ) 100109 mmHg ( inclusive ) sit systolic blood pressure ( SSBP ) &lt; 180 mmHg 2 week placebo runin period Home Blood Pressure : diastolic blood pressure ( DBP ) home â‰¥ 85 mmHg last week placebo runin period Normal Electrocardiogram ( ECG ) , first degree Atrioventricular block change consider clinically significant Secondary severe hypertension History cerebro cardiovascular complication Type 1 Type 2 diabetes drug treatment Severe renal hepatic insufficiency</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Lercanidipine</keyword>
	<keyword>Calcium antagonist</keyword>
	<keyword>Enalapril</keyword>
</DOC>